Tiffany Mahmood

Tiffany Mahmood

Tiffany Mahmood
New York
+1 212 459 7170

Tiffany Mahmood is a partner in the firm’s Litigation Department and a member of its Intellectual Property group. She joined Goodwin in 2015.

Ms. Mahmood focuses her practice on patent matters, including pharmaceuticals, chemicals and biotechnology. Her experience also includes representing clients in the automotive and computer software fields in the patent context, as well as clients in the fashion industry on trademark and copyright-related matters.

Professional Experience

Ms. Mahmood has experience representing companies in all stages of patent litigation, from pre-suit investigation through trial. Some of her recent engagements include:

  • Representing Vizbee in a defense of patent infringement lawsuit regarding telecasting technology, filed in the Southern District of New York.
  • Represented Sun Pharmaceuticals, Inc. at trial in a patent infringement case involving a generic drug product to treat rosacea. The case is currently pending in the District of Delaware.
  • Represented Taro Pharmaceuticals, Inc. in a patent infringement case filed in the Eastern District of Texas involving a generic tablet used to treat iron overload caused by blood transfusion. The case settled favorably.
  • Represented AMAG Pharmaceuticals, Inc. in a patent infringement case filed in the District of New Jersey relating to AMAG’s Feraheme® product. The case settled favorably.
  • Represented Actavis Laboratories FL, Inc. in a trial victory over Tris Pharma in federal court in Delaware, paving the way for Actavis to launch a generic version of Quillivant XR® (methylphenidate hydrochloride), a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The court found invalid five patents covering Quillivant®’s formulation and use, which would have protected the drug from generic competition for another 14 years.
  • Represented Teva in a patent infringement action filed by Otsuka relating to Teva’s filing of abbreviated new drug applications for generic versions of Otsuka’s drug Abilify® (aripiprazole). The case against Teva settled favorably before trial.

Professional Experience

Prior to joining Goodwin, Ms. Mahmood was an associate in the New York office on Kenyon & Kenyon.




Fordham University School of Law


Fordham University School of Law


Imperial College of Science, Technology and Medicine (London)



  • New York
  • New Jersey


  • U.S. District Court for the Southern District of New York

Recognition & Awards

Ms. Mahmood has been recognized by The Best Lawyers in America Ones to Watch for her work in Litigation - Patent and Patent Law 2022.

Ms. Mahmood was named to The Best Lawyers in America 2021: Ones to Watch.


Ms. Mahmood moderated patent law panels for the 2011, 2012 and 2015 Annual Fordham Intellectual Property Law and Policy Conference.

While attending law school, Ms. Mahmood was the editor-in-chief for the Fordham Intellectual Property, Media & Entertainment Law Journal.